{
  "guideline": {
    "id": "PA166153492",
    "name": "Annotation of FDA Label for brivaracetam and CYP2C19",
    "source": "FDA",
    "version": 37,
    "url": "https://www.pharmgkb.org/labelAnnotation/PA166153492",
    "relatedChemicals": [
      {
        "id": "PA166153491",
        "name": "brivaracetam",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA124",
        "name": "cytochrome P450 family 2 subfamily C member 19",
        "symbol": "CYP2C19"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166307661",
      "name": "Recommendation Annotation PA166307661",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166153491",
          "name": "brivaracetam",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452157580,
        "html": "<p>&quot;CYP2C19 poor metabolizers and patients using inhibitors of CYP2C19 may require dose reduction.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2C19": "Poor Metabolizer"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    },
    {
      "id": "PA166310401",
      "name": "Recommendation Annotation PA166310401",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166153491",
          "name": "brivaracetam",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452211580,
        "html": "<p>&quot;CYP2C19 poor metabolizers and patients using inhibitors of CYP2C19 may require dose reduction.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "CYP2C19": "Likely Poor Metabolizer"
      },
      "dosingInformation": true,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": false
    }
  ],
  "citations": [
    {
      "pmid": null,
      "title": "Drugs@FDA: Drug Product Briviact (brivaracetam), NDA205836, UCB, Inc.",
      "authors": [],
      "journal": null,
      "year": -1,
      "_sameAs": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=205836"
    }
  ],
  "version": "2024-02-29-20-19"
}